切换至 "中华医学电子期刊资源库"

中华移植杂志(电子版) ›› 2017, Vol. 11 ›› Issue (02) : 114 -118. doi: 10.3877/cma.j.issn.1674-3903.2017.02.012

所属专题: 文献

综述

肝移植术后肠道菌群失调的研究进展
王垒1, 彭贵主1,(), 叶啟发2   
  1. 1. 430071 武汉大学中南医院 武汉大学肝胆疾病研究院 武汉大学移植医学中心 移植医学湖北省重点实验室
    2. 430071 武汉大学中南医院 武汉大学肝胆疾病研究院 武汉大学移植医学中心 移植医学湖北省重点实验室;410013 长沙,中南大学湘雅三医院 卫生部移植医学工程技术研究中心
  • 收稿日期:2016-08-29 出版日期:2017-05-25
  • 通信作者: 彭贵主
  • 基金资助:
    国家自然科学基金新疆联合基金重点支持项目(U1403222); 武汉市科技局项目(20160601010033)

The progress of alteration of intestinal flora after liver transplantation

Lei Wang1, Guizhu Peng1,(), Qifa Ye2   

  1. 1. Zhongnan Hospital of Wuhan University, Institute of Hepatobiliary Disease of Wuhan University, Transplant Center of Wuhan University, Hubei Key Laboratory of Medical Technology on Transplantation, Wuhan 430071, China
    2. Zhongnan Hospital of Wuhan University, Institute of Hepatobiliary Disease of Wuhan University, Transplant Center of Wuhan University, Hubei Key Laboratory of Medical Technology on Transplantation, Wuhan 430071, China;Research Center of National Health Ministry on Transplantation Medicine and Technology, the Third Xiangya Hospital of Central South University, Changsha 410013, China
  • Received:2016-08-29 Published:2017-05-25
  • Corresponding author: Guizhu Peng
  • About author:
    Corresponding author: Peng Guizhu, Email:
引用本文:

王垒, 彭贵主, 叶啟发. 肝移植术后肠道菌群失调的研究进展[J/OL]. 中华移植杂志(电子版), 2017, 11(02): 114-118.

Lei Wang, Guizhu Peng, Qifa Ye. The progress of alteration of intestinal flora after liver transplantation[J/OL]. Chinese Journal of Transplantation(Electronic Edition), 2017, 11(02): 114-118.

近年来,随着分子生物学技术的飞速发展,肠道微生物作为一个"器官"受到越来越广泛的关注。肠道微生物与机体免疫系统相互作用,共同维持机体的免疫稳态。肠道菌群失调可能是肝移植术后发生感染、排斥反应等并发症的重要原因。通过选择性去污、缺血预处理、益生菌和粪便菌群移植等手段干预肠道微生物可在一定程度上改善肝移植受者预后。

Recently, intestinal flora, as an organ, is being paid much more attention accompanied with rapid development of molecular biotechnology. Intestinal microbiota maintains the balance of immune state through interaction with immune system. Intestinal dysbacteriosis might be one of the reasons for complications after liver transplantation such as infection and rejection. Strategies such as selective digestive decontamination, ischemic preconditioning, probiotics and fecal microbiota transplantation can improve prognosis of liver transplantation.

1
Ren Z,Cui G,Lu H, et al. Liver ischemic preconditioning (IPC) improves intestinal microbiota following liver transplantation in rats through 16s rDNA-based analysis of microbial structure shift[J]. PLoS One, 2013, 8(10): e75950.
2
童荔,杨志勤,易小猛, 等. 肝移植术后肠道菌群失调及其危险因素分析[J/CD]. 中华临床医师杂志:电子版, 2014, 8(5): 868-872.
3
Lu H,He J,Wu Z, et al. Assessment of microbiome variation during the perioperative period in liver transplant patients: a retrospective analysis[J]. Microb Ecol, 2013, 65(3): 781-791.
4
Bruls T,Weissenbach J. The human metagenome: our other genome?[J]. Hum Mol Genet, 2011, 20(R2): R142-R148.
5
Backhed F,Ley RE,Sonnenburg JL, et al. Host-bacterial mutualism in the human intestine[J]. Science, 2005, 307(5717): 1915-1920.
6
Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome[J]. Nature, 2012, 486(7402): 207-214.
7
Possemiers S,Bolca S,Verstraete W, et al. The intestinal microbiome: a separate organ inside the body with the metabolic potential to influence the bioactivity of botanicals[J]. Fitoterapia, 2011, 82(1): 53-66.
8
Bruzzese E,Callegari ML,Raia V, et al. Disrupted intestinal microbiota and intestinal inflammation in children with cystic fibrosis and its restoration with Lactobacillus GG: a randomised clinical trial[J]. PLoS One, 2014, 9(2): e87796.
9
Kamada N,Seo SU,Chen GY, et al. Role of the gut microbiota in immunity and inflammatory disease[J]. Nat Rev Immunol, 2013, 13(5): 321-335.
10
Arumugam M,Raes J,Pelletier E, et al. Enterotypes of the human gut microbiome[J]. Nature, 2011, 473(7346): 174-180.
11
Choi JH,Kim GB,Cha CJ. Spatial heterogeneity and stability of bacterial community in the gastrointestinal tracts of broiler chickens[J]. Poult Sci, 2014, 93(8): 1942-1950.
12
Fukuda S,Toh H,Taylor TD, et al. Acetate-producing bifidobacteria protect the host from enteropathogenic infection via carbohydrate transporters[J]. Gut Microbes, 2012, 3(5): 449-454.
13
Sayin SI,Wahlstrom A,Felin J, et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist[J]. Cell Metab, 2013, 17(2): 225-235.
14
Li F,Jiang C,Krausz KW, et al. Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity[J]. Nat Commun, 2013, 4: 2384.
15
Shankar V,Hamilton MJ,Khoruts A, et al. Species and genus level resolution analysis of gut microbiota in Clostridium difficile patients following fecal microbiota transplantation[J]. Microbiome, 2014, 2: 13.
16
Renz H,Brandtzaeg P,Hornef M. The impact of perinatal immune development on mucosal homeostasis and chronic inflammation[J]. Nat Rev Immunol, 2012, 12(1): 9-23.
17
Round JL,Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease[J]. Nat Rev Immunol, 2009, 9(5): 313-323.
18
Bouskra D,Brezillon C,Berard M, et al. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis[J]. Nature, 2008, 456(7221): 507-510.
19
Laycock G,Sait L,Inman C, et al. A defined intestinal colonization microbiota for gnotobiotic pigs[J]. Vet Immunol Immunopathol, 2012, 149(3-4): 216-224.
20
Gaboriau-Routhiau V,Rakotobe S,Lecuyer E, et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses[J]. Immunity, 2009, 31(4): 677-689.
21
Ivanov II,Atarashi K,Manel N, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria[J]. Cell, 2009, 139(3): 485-498.
22
Hand TW,Dos SL,Bouladoux N, et al. Acute gastrointestinal infection induces long-lived microbiota-specific T cell responses[J]. Science, 2012, 337(6101): 1553-1556.
23
Yoon WS,Choi HJ,Park YK. Salmonella typhimurium harboring plasmid expressing interleukin-12 induced attenuation of infection and protective immune responses[J]. J Gen Appl Microbiol, 2011, 57(2): 115-122.
24
Round JL,Lee SM,Li J, et al. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota[J]. Science, 2011, 332(6032): 974-977.
25
Atarashi K,Tanoue T,Shima T, et al. Induction of colonic regulatory T cells by indigenous Clostridium species[J]. Science, 2011, 331(6015): 337-341.
26
Maynard CL,Elson CO,Hatton RD, et al. Reciprocal interactions of the intestinal microbiota and immune system[J]. Nature, 2012, 489(7415): 231-241.
27
《中华消化杂志》编委会, 王兴鹏. 肠道菌群失调诊断治疗建议[J]. 中华消化杂志, 2009, 29(5): 335-337.
28
Xu MQ,Cao HL,Wang WQ, et al. Fecal microbiota transplantation broadening its application beyond intestinal disorders[J]. World J Gastroenterol, 2015, 21(1): 102-111.
29
Mckay S,Gaudier E,Campbell DI, et al. Environmental enteropathy: new targets for nutritional interventions[J]. Int Health, 2010, 2(3): 172-180.
30
Armougom F,Henry M,Vialettes B, et al. Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients[J]. PLoS One, 2009, 4(9): e7125.
31
Rizzello M,De Angelis F,Campanile FC, et al. Effect of gastrointestinal surgical manipulation on metabolic syndrome: a focus on metabolic surgery[J]. Gastroenterol Res Pract, 2012: 670418.
32
Stefater MA,Wilson-Perez HE,Chambers AP, et al. All bariatric surgeries are not created equal: insights from mechanistic comparisons[J]. Endocr Rev, 2012, 33(4): 595-622.
33
廖博雅,王莎莎,张军东, 等. 肠道微生物在人类疾病中的作用[J]. 胃肠病学, 2015, 20(2): 126-128.
34
Malamut G,Verkarre V,Suarez F, et al. The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease[J]. Am J Gastroenterol, 2010, 105(10): 2262-2275.
35
Compare D,Coccoli P,Rocco A, et al. Gut-liver axis: the impact of gut microbiota on non alcoholic fatty liver disease[J]. Nutr Metab Cardiovasc Dis, 2012, 22(6): 471-476.
36
Xie YR,Liu SL,Liu X, et al. Intestinal microbiota and innate immunity-related gene alteration in cirrhotic rats with liver transplantation[J]. Transplant Proc, 2011, 43(10): 3973-3979.
37
刘霞,刘社兰,解奕瑞, 等. 基于16S rRNA基因和细菌基因组间重复序列的DNA指纹图谱技术对肝硬化大鼠肝移植后肠道菌群多样性的研究[J]. 中国微生态学杂志, 2010, 22(3): 193-198.
38
Xie Y,Luo Z,Li Z, et al. Structural shifts of fecal microbial communities in rats with acute rejection after liver transplantation[J]. Microb Ecol, 2012, 64(2): 546-554.
39
Ren Z,Jiang J,Lu H, et al. Intestinal microbial variation may predict early acute rejection after liver transplantation in rats[J]. Transplantation, 2014, 98(8): 844-852.
40
Wu ZW,Ling ZX,Lu HF, et al. Changes of gut bacteria and immune parameters in liver transplant recipients[J]. Hepatobiliary Pancreat Dis Int, 2012, 11(1): 40-50.
41
Arai M,Mochida S,Ohno A, et al. Selective bowel decontamination of recipients for prevention against liver injury following orthotopic liver transplantation: evaluation with rat models[J]. Hepatology, 1998, 27(1): 123-127.
42
Katchman E,Marquez M,Bazerbachi F, et al. A comparative study of the use of selective digestive decontamination prophylaxis in living-donor liver transplant recipients[J]. Transpl Infect Dis, 2014, 16(4): 539-547.
43
Mccafferty K,Forbes S,Thiemermann C, et al. The challenge of translating ischemic conditioning from animal models to humans: the role of comorbidities[J]. Dis Model Mech, 2014, 7(12): 1321-1333.
44
Wu J,Feng X,Huang H, et al. Remote ischemic conditioning enhanced the early recovery of renal function in recipients after kidney transplantation: a randomized controlled trial[J]. J Surg Res, 2014, 188(1): 303-308.
45
Mullard A. Microbiology: the inside story[J]. Nature, 2008, 453(7195): 578-580.
46
Rayes N,Seehofer D,Theruvath T, et al. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation-a randomized, double-blind trial[J]. Am J Transplant, 2005, 5(1): 125-130.
47
Xing HC,Li LJ,Xu KJ, et al. Protective role of supplement with foreign Bifidobacterium and Lactobacillus in experimental hepatic ischemia-reperfusion injury[J]. J Gastroenterol Hepatol, 2006, 21(4): 647-656.
48
Ren ZG,Liu H,Jiang JW, et al. Protective effect of probiotics on intestinal barrier function in malnourished rats after liver transplantation[J]. Hepatobiliary Pancreat Dis Int, 2011, 10(5): 489-496.
49
Xie Y,Chen H,Zhu B, et al. Effect of intestinal microbiota alteration on hepatic damage in rats with acute rejection after liver transplantation[J]. Microb Ecol, 2014, 68(4): 871-880.
50
El FR,Bangar H,Haslam DB. The molecular basis of Clostridium difficile disease and host response[J]. Curr Opin Gastroenterol, 2015, 31(1): 24-29.
51
Zhang F,Luo W,Shi Y, et al. Should we standardize the 1, 700-year-old fecal microbiota transplantation?[J]. Am J Gastroenterol, 2012, 107(11): 1755, 1755-1756.
52
Eiseman B,Silen W,Bascom GS, et al. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis[J]. Surgery, 1958, 44(5): 854-859.
53
Armstrong MJ,Pathmakanthan S,Iqbal TH. Fecal microbiota transplantation for Clostridium difficile infection[J]. JAMA, 2015, 313(7): 725-726.
54
Ray A,Smith R,Breaux J. Fecal microbiota transplantation for Clostridium difficile infection: the Ochsner experience[J]. Ochsner J, 2014, 14(4): 538-544.
55
Kelly CR,de Leon L,Jasutkar N. Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results[J]. J Clin Gastroenterol, 2012, 46(2): 145-149.
56
Gough E,Shaikh H,Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection[J]. Clin Infect Dis, 2011, 53(10): 994-1002.
57
Kim JE,Gweon TG,Yeo CD, et al. A case of Clostridium difficile infection complicated by acute respiratory distress syndrome treated with fecal microbiota transplantation[J]. World J Gastroenterol, 2014, 20(35): 12687-12690.
58
Bakken JS,Borody T,Brandt LJ, et al. Treating Clostridium difficile infection with fecal microbiota transplantation[J]. Clin Gastroenterol Hepatol, 2011, 9(12): 1044-1049.
59
Angelberger S,Reinisch W,Makristathis A, et al. Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation[J]. Am J Gastroenterol, 2013, 108(10): 1620-1630.
60
van Nood E,Dijkgraaf MG,Keller JJ. Duodenal infusion of feces for recurrent Clostridium difficile[J]. N Engl J Med, 2013, 368(22): 2145.
61
Grehan MJ,Borody TJ,Leis SM, et al. Durable alteration of the colonic microbiota by the administration of donor fecal flora[J]. J Clin Gastroenterol, 2010, 44(8): 551-561.
62
Youngster I,Hohmann EL. Fecal microbiota transplantation for Clostridium difficile infection-reply[J]. JAMA, 2015, 313(7): 726.
63
Rao K,Young VB. Fecal microbiota transplantation for the management of Clostridium difficile infection[J]. Infect Dis Clin North Am, 2015, 29(1): 109-122.
64
Sipponen T,Kolho KL. Fecal calprotectin in diagnosis and clinical assessment of inflammatory bowel disease[J]. Scand J Gastroenterol, 2015, 50(1): 74-80.
[1] 陈进宏. 腹腔镜活体供肝获取规范与创新[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 324-324.
[2] 中华医学会器官移植学分会, 中国医师协会器官移植医师分会. 中国活体肝移植供者微创手术技术指南(2024版)[J/OL]. 中华普通外科学文献(电子版), 2024, 18(04): 241-252.
[3] 仲福顺, 余露, 范晓礼, 叶啟发. 肝移植治疗肝上皮样血管内皮瘤一例[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 293-297.
[4] 刘冉佳, 崔向丽, 周效竹, 曲伟, 朱志军. 儿童肝移植受者健康相关生存质量评价的荟萃分析[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 302-309.
[5] 贺健, 张骊, 王洪海, 蒋文涛. 肝移植术后脾功能亢进转归及治疗研究进展[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 310-314.
[6] 胡宁宁, 赵延荣, 王栋, 王胜亮, 郭源. FMNL3与肝细胞癌肝移植受者预后的相关性研究[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 283-288.
[7] 方道成, 唐春华, 胡媛媛. 肠道菌群对草酸钙肾结石形成的影响[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 509-513.
[8] 王俊楠, 刘晔, 李若涵, 叶青松. 间充质干细胞调控肠脑轴治疗神经系统疾病的潜力[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(05): 313-319.
[9] 中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[10] 傅斌生, 冯啸, 杨卿, 曾凯宁, 姚嘉, 唐晖, 刘剑戎, 魏绪霞, 易慧敏, 易述红, 陈规划, 杨扬. 脂肪变性供肝在成人劈离式肝移植中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 789-794.
[11] 魏志鸿, 刘建勇, 吴小雅, 杨芳, 吕立志, 江艺, 蔡秋程. 肝移植术后急性移植物抗宿主病的诊治(附四例报告)[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 846-851.
[12] 中华医学会器官移植学分会, 中华医学会外科学分会外科手术学学组, 中华医学会外科学分会移植学组, 华南劈离式肝移植联盟. 劈离式供肝儿童肝移植中国临床操作指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 593-601.
[13] 刘军, 丘文静, 孙方昊, 李松盈, 易述红, 傅斌生, 杨扬, 罗慧. 在体与离体劈离式肝移植在儿童肝移植中的应用比较[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 688-693.
[14] 杜军霞, 赵小淋, 王浩然, 高志远, 王曼茜, 万楠熙, 张冬, 丁潇楠, 任琴琴, 段颖洁, 汤力, 朱晗玉. 2 型糖尿病的血液透析患者肠道微生物组学高通量测序分析[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 313-320.
[15] 李秀玲, 连少锋, 荣刘涛, 李登峰, 饶蕴玉. 利巴韦林联合复方嗜酸乳杆菌治疗轮状病毒肠炎患儿的临床研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(04): 369-372.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?